Cite
Lassen P, Huang SH, Su J, et al. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts. Int J Cancer. 2021;doi: 10.1002/ijc.33876.
Lassen, P., Huang, S. H., Su, J., Waldron, J., Andersen, M., Primdahl, H., Johansen, J., Kristensen, C. A., Andersen, E., Eriksen, J. G., Hansen, C. R., Alsner, J., Lilja-Fisher, J., Bratman, S. V., Ringash, J., Kim, J., Hope, A., Spreafico, A., de Almeida, J., Xu, W., O'Sullivan, B., & Overgaard, J. (2021). Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts. International journal of cancer, . https://doi.org/10.1002/ijc.33876
Lassen, Pernille, et al. "Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts." International journal of cancer vol. (2021). doi: https://doi.org/10.1002/ijc.33876
Lassen P, Huang SH, Su J, Waldron J, Andersen M, Primdahl H, Johansen J, Kristensen CA, Andersen E, Eriksen JG, Hansen CR, Alsner J, Lilja-Fisher J, Bratman SV, Ringash J, Kim J, Hope A, Spreafico A, de Almeida J, Xu W, O'Sullivan B, Overgaard J. Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts. Int J Cancer. 2021 Nov 18; doi: 10.1002/ijc.33876. Epub 2021 Nov 18. PMID: 34792199.
Copy
Download .nbib